Benzinga's Top Upgrades, Downgrades For September 11, 2020

Loading...
Loading...

Upgrades

  • According to Wedbush, the prior rating for Sage Therapeutics Inc SAGE was changed from Neutral to Outperform. Sage Therapeutics earned $2.08 in the second quarter, compared to $3.28 in the year-ago quarter. The current stock performance of Sage Therapeutics shows a 52-week-high of $167.82 and a 52-week-low of $25.01. Moreover, at the end of the last trading period, the closing price was at $54.25.
  • According to Stifel, the prior rating for Photronics Inc PLAB was changed from Hold to Buy. For the third quarter, Photronics had an EPS of $0.17, compared to year-ago quarter EPS of $0.10. At the moment, the stock has a 52-week-high of $16.75 and a 52-week-low of $8.31. Photronics closed at $8.73 at the end of the last trading period.
  • For ACM Research Inc ACMR, Stifel upgraded the previous rating of Hold to the current rating Buy. ACM Research earned $0.29 in the second quarter, compared to $0.26 in the year-ago quarter. The current stock performance of ACM Research shows a 52-week-high of $113.87 and a 52-week-low of $12.51. Moreover, at the end of the last trading period, the closing price was at $60.66.
  • Cowen & Co. upgraded the previous rating for Adobe Inc ADBE from Market Perform to Outperform. In the second quarter, Adobe showed an EPS of $2.45, compared to $1.83 from the year-ago quarter. The stock has a 52-week-high of $536.88 and a 52-week-low of $255.13. At the end of the last trading period, Adobe closed at $476.26.
  • According to Needham, the prior rating for PerkinElmer Inc PKI was changed from Hold to Buy. For the second quarter, PerkinElmer had an EPS of $1.57, compared to year-ago quarter EPS of $1.00. The current stock performance of PerkinElmer shows a 52-week-high of $123.21 and a 52-week-low of $62.91. Moreover, at the end of the last trading period, the closing price was at $113.39.
  • Baird upgraded the previous rating for SunPower Corp SPWR from Neutral to Outperform. In the second quarter, SunPower showed an EPS of $0.22, compared to $0.22 from the year-ago quarter. The current stock performance of SunPower shows a 52-week-high of $15.57 and a 52-week-low of $4.03. Moreover, at the end of the last trading period, the closing price was at $10.66.
  • According to Cowen & Co., the prior rating for Domino's Pizza Inc DPZ was changed from Market Perform to Outperform. In the second quarter, Domino's Pizza showed an EPS of $2.99, compared to $2.19 from the year-ago quarter. The current stock performance of Domino's Pizza shows a 52-week-high of $424.72 and a 52-week-low of $227.50. Moreover, at the end of the last trading period, the closing price was at $389.25.
  • For LyondellBasell Industries NV LYB, JP Morgan upgraded the previous rating of Neutral to the current rating Overweight. For the second quarter, LyondellBasell Industries had an EPS of $0.68, compared to year-ago quarter EPS of $2.70. At the moment, the stock has a 52-week-high of $98.91 and a 52-week-low of $33.71. LyondellBasell Industries closed at $70.91 at the end of the last trading period.

 

Downgrades

  • According to Wedbush, the prior rating for Virtusa Corp VRTU was changed from Outperform to Neutral. Virtusa earned $0.20 in the first quarter, compared to $0.41 in the year-ago quarter. At the moment, the stock has a 52-week-high of $52.81 and a 52-week-low of $19.48. Virtusa closed at $50.42 at the end of the last trading period.
  • For Satsuma Pharmaceuticals Inc STSA, Mizuho downgraded the previous rating of Buy to the current rating Neutral. In the second quarter, Satsuma Pharmaceuticals earned $0.65. The stock has a 52-week-high of $36.10 and a 52-week-low of $4.55. At the end of the last trading period, Satsuma Pharmaceuticals closed at $5.62.
  • For Satsuma Pharmaceuticals Inc STSA, Credit Suisse downgraded the previous rating of Outperform to the current rating Underperform. In the second quarter, Satsuma Pharmaceuticals earned $0.65. At the moment, the stock has a 52-week-high of $36.10 and a 52-week-low of $4.55. Satsuma Pharmaceuticals closed at $5.62 at the end of the last trading period.

 

Initiations

  • Truist Securities initiated coverage on Select Interior Concepts Inc SIC with a Buy rating. The price target for Select Interior Concepts is set to $10.00. In the second quarter, Select Interior Concepts showed an EPS of $0.13, compared to $0.08 from the year-ago quarter. At the moment, the stock has a 52-week-high of $13.76 and a 52-week-low of $1.25. Select Interior Concepts closed at $6.32 at the end of the last trading period.
  • With a current rating of Buy, BTIG initiated coverage on Redhill Biopharma Ltd RDHL. The price target seems to have been set at $26.00 for Redhill Biopharma. For the second quarter, Redhill Biopharma had an EPS of $0.04, compared to year-ago quarter EPS of $0.04. At the moment, the stock has a 52-week-high of $10.96 and a 52-week-low of $3.26. Redhill Biopharma closed at $10.16 at the end of the last trading period.
  • Berenberg initiated coverage on Cabot Microelectronics Corp CCMP with a Hold rating. The price target for Cabot Microelectronics is set to $155.00. For the third quarter, Cabot Microelectronics had an EPS of $1.80, compared to year-ago quarter EPS of $1.59. The stock has a 52-week-high of $174.87 and a 52-week-low of $85.26. At the end of the last trading period, Cabot Microelectronics closed at $144.43.
  • Needham initiated coverage on BioTelemetry Inc BEAT with a Buy rating. The price target for BioTelemetry is set to $52.00. In the second quarter, BioTelemetry showed an EPS of $0.35, compared to $0.53 from the year-ago quarter. At the moment, the stock has a 52-week-high of $55.85 and a 52-week-low of $27.35. BioTelemetry closed at $36.67 at the end of the last trading period.
  • For iRhythm Technologies Inc IRTC, Needham initiated coverage, by setting the current rating at Hold. iRhythm Technologies earned $0.75 in the second quarter, compared to $0.46 in the year-ago quarter. The current stock performance of iRhythm Technologies shows a 52-week-high of $232.58 and a 52-week-low of $56.24. Moreover, at the end of the last trading period, the closing price was at $211.10.
  • Rosenblatt initiated coverage on Skyworks Solutions Inc SWKS with a Buy rating. The price target for Skyworks Solutions is set to $160.00. In the third quarter, Skyworks Solutions showed an EPS of $1.25, compared to $1.35 from the year-ago quarter. The current stock performance of Skyworks Solutions shows a 52-week-high of $154.24 and a 52-week-low of $67.90. Moreover, at the end of the last trading period, the closing price was at $135.23.
Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: UpgradesDowngradesInitiationIntraday UpdateAnalyst RatingsInitiationstop upgrades
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...